JIANGSU AIDEA PHARMACEUTICAL revenue for the last year amounted to 411.00 M CNY, the most of which — 176.99 M CNY — came from its highest performing source at the moment, Crude Urokinase, the year earlier bringing 103.23 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU AIDEA PHARMACEUTICAL 411.36 M CNY, and the year before that — 244.22 M CNY.